Business Day

Engineering Better Therapies: A Nigerian scientist’s journey

In drug development, success often hinges on a deceptively simple question: how will the body respond? For Dr. Kidochukwu ...

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
NC Biotech

J&J to add another new drug-making facility in Wilson

J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...

As essential antibiotics fail, regulator mulls R&D push, curbs on misuse

To address rising threat of antimicrobial resistance, India’s drug regulator plans an overhaul of regulations for antibiotics ...
Healio

FDA qualifies first AI tool to accelerate MASH drug development

Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...
pharmaceuticalcommerce

What MFN Pricing Means for Future Drug Development

In the final part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory and author of The Price of Global Health, previews his December column, ...
JD Supra

FDA Issued Updated Patient-Focused Drug Development Guidance on Clinical Outcome Assessments

The U.S. Food and Drug Administration (FDA) issued its third Patient-Focused Drug Development (PFDD) guidance titled, “Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments ...
Yale Environment 360

Pioneering drug development, one company at a time

Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...
BioSpace

As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation?

This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question whether they will be enough to net their developers a significant share of the ...
Frontiers

Computational-aided drug design strategies for drug discovery and development against oral diseases

1 School of BioSciences, Faculty of Science, University of Melbourne, Parkville, VIC, Australia 2 School of Stomatology, Shandong Second Medical University, Weifang, China Oral diseases, including ...
CNN

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
Becker's Hospital Review

FDA rewrites biosimilar rules to slash drug costs

HHS Secretary Robert F. Kennedy Jr., FDA Commissioner Marty Makary, MD, and CMS Administrator Mehmet Oz, MD, announced new FDA guidance aimed at making biosimilar drug development faster and less ...